Industry News | News List
AbbVie's oral JAK inhibitor Rinvoq (upatinib) approved by NMPA
2022-03-11
AbbVie recently announced that China’s National Medical Products Administration (NMPA) has approved
Genentech’s Evrysdi (risdiplam) Granted FDA Priority Review for Treatment of Pre-Symptomatic Babies Under 2 Months of Age With Spinal Muscular Atrophy (SMA)
2022-02-11
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (
Novartis' asciminib bests Pfizer's Bosulif in phase 3 leukemia trial
2021-11-02
Novartis’ asciminib hasoutperformedPfizer’s Bosulif in a phase 3 chronic myeloid leukemia (CML) stud
Hengrui announces new drug SHR7280
2021-10-16
On October 11, 2021, Jiangsu Hengrui Pharmaceuticals Co., Ltd. announced that SHR0302, for the treat
Novartis secures new approval in China for Cosentyx® (secukinumab) in pediatric psoriasis
2021-08-23
August 17, 2021 – Novartis today announced that the China National Medical Products Administration (
USFDA approves KIT inhibitor Ayvakit (Avatinib)
2021-06-25
CStone's partner Blueprint Medicines recently announced that the U.S. Food and Drug Administrati
AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab (SKYRIZI®) Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with Moderate to Severe Crohn's Disease
2021-06-01
Late-breaking data analyses presented by AbbVie (NYSE: ABBV) at Digestive Disease Week®(DDW) Virtual
Xofluza was approved in China
2021-05-13
On April 29, 2021, Roche China announced that its innovative influenza drug Xofluza® (Mabaloxavir) h
Gilead’s Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI
2021-03-15
Gilead Sciences, Inc. (Nasdaq: GILD) today presented additional results from the Phase 2/3 CAPELLA t
BeiGene Announces EMA Acceptance of its Marketing Authorization Application for BRUKINSA® (Zanubrutinib) for the Treatment of Patients with WM
2021-02-25
On June 18, 2020, BeiGene, Ltd. (“BeiGene” or the “Company”), a commercial-stage biotechnology compa